Literature DB >> 15834052

Risk of lymphoma in patients with RA treated with anti-TNFalpha agents.

J P Franklin1, D P M Symmons, A J Silman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15834052      PMCID： PMC1755469          DOI： 10.1136/ard.2005.035311

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  16 in total

1.  Intravascular lymphoma presenting as symmetric polyarthritis.

Authors:  J von Kempis; G Köhler; E W Herbst; H H Peter
Journal:  Arthritis Rheum       Date:  1998-06

2.  Lack of certainty on the diagnosis of acute intermittent porphyria: comment on the concise communication by Cohen et al.

Authors:  A L Herrick; K E McColl
Journal:  Arthritis Rheum       Date:  1998-01

3.  The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.

Authors:  J A Baltus; J W Boersma; A P Hartman; J P Vandenbroucke
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

4.  Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis.

Authors:  H A Isomäki; T Hakulinen; U Joutsenlahti
Journal:  J Chronic Dis       Date:  1978

5.  Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment.

Authors:  L J Kinlen
Journal:  Am J Med       Date:  1985-01-21       Impact factor: 4.965

6.  Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells.

Authors:  A Wallgren; R Festin; C Gidlöf; M Dohlsten; T Kalland; T H Tötterman
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

7.  Cancer morbidity in rheumatoid arthritis.

Authors:  P Prior; D P Symmons; C F Hawkins; D L Scott; R Brown
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

8.  A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.

Authors:  S M Lens; K Tesselaar; B F den Drijver; M H van Oers; R A van Lier
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

9.  Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.

Authors:  Frederick Wolfe; Kaleb Michaud
Journal:  Arthritis Rheum       Date:  2004-06

10.  Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study.

Authors:  A J Silman; J Petrie; B Hazleman; S J Evans
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103
View more
  7 in total

1.  Steroid-unresponsive neurosarcoidosis successfully treated with adalimumab.

Authors:  Michael Marnane; Timothy Lynch; Jaqueline Scott; John Stack; Peter J Kelly
Journal:  J Neurol       Date:  2009-01-31       Impact factor: 4.849

Review 2.  Is there truly a risk of lymphoma from biologic therapies?

Authors:  Erica Dommasch; Joel M Gelfand
Journal:  Dermatol Ther       Date:  2009 Sep-Oct       Impact factor: 2.851

3.  Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance system.

Authors:  Hélène Théophile; Thierry Schaeverbeke; Ghada Miremont-Salamé; Abdelilah Abouelfath; Valentine Kahn; Françoise Haramburu; Bernard Bégaud
Journal:  Drug Saf       Date:  2011-07-01       Impact factor: 5.606

4.  Biological treatment in rheumatic diseases: results from a longitudinal surveillance: adverse events.

Authors:  L Konttinen; V Honkanen; T Uotila; J Pöllänen; M Waahtera; M Romu; K Puolakka; M Vasala; A Karjalainen; R Luukkainen; D C Nordström
Journal:  Rheumatol Int       Date:  2006-01-10       Impact factor: 2.631

5.  Rheumatoid Arthritis Saudi Database (RASD): Disease Characteristics and Remission Rates in a Tertiary Care Center.

Authors:  Hani Almoallim; Rola Hassan; Mohamed Cheikh; Hanan Faruqui; Reem Alquraa; Ayman Eissa; Aous Alhazmi; Roaa Alsolaimani; Nahed Janoudi
Journal:  Open Access Rheumatol       Date:  2020-08-06

6.  Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.

Authors:  Matthew L Stoll; Alisa C Gotte
Journal:  Biologics       Date:  2008-06

7.  Lymphoma and metastatic breast cancer presenting with palpable axillary and inguinal lymphadenopathy in a 40-year-old man with rheumatoid arthritis on anti-tumor necrosis factor α therapy: a case report.

Authors:  Gourab Datta; Dorendra Maisnam
Journal:  J Med Case Rep       Date:  2013-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.